Metraipolis › archive › dc_9db54c0beb59

Efficacy of Subsequent Therapy in Patients with Hormone-Positive Advanced Breast Cancer with Disease Progression After CDK4/6 Inhibitor Therapy: Multicenter… — Europe PMC PMID:41156245

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41156245
DOI
10.3390/jcm14207376
License (as archived)
solo-consultazione
Archived
2026-11-09T05:25:36.626Z
SHA-256 of the archived text
70ddc4d636ca0fe351a0013586bae910543565e967f23c2004b4c78f34249c48
Stable URL of this page
https://metraipolis.com/documento/dc_9db54c0beb59

How to cite

Efficacy of Subsequent Therapy in Patients with Hormone-Positive Advanced Breast Cancer with Disease Progression After CDK4/6 Inhibitor Therapy: Multicenter… — Europe PMC PMID:41156245 — Europe PMC (en), https://europepmc.org/article/MED/41156245 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9db54c0beb59 (Metraipolis archive dc_9db54c0beb59, sha256 70ddc4d636ca0fe351a0013586bae910543565e967f23c2004b4c78f34249c48)
BibTeX
@misc{dc9db54c0beb59,
  title = {Efficacy of Subsequent Therapy in Patients with Hormone-Positive Advanced Breast Cancer with Disease Progression After CDK4/6 Inhibitor Therapy: Multicenter… — Europe PMC PMID:41156245},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41156245},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9db54c0beb59; sha256 70ddc4d636ca0fe351a0013586bae910543565e967f23c2004b4c78f34249c48},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41156245. Agents can read the archived copy with the MCP tool read_document.